30:09

Highlights from ASH 2023: A Canadian Perspective on CLL

22:22

Immunotherapy for Kidney Transplant Patients with Skin Cancer

32:29

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on ...

59:26

ERN-EuroBloodNet Topic on Focus on CT - Management of heavy menstrual bleeding

1:06:38

Carbon Management: Year 2024 in Review

57:57

MLRN - Using beneficial ownership data for large-scale risk assessment in public procurement

26:35

ASH 2024: Updates on CLL

27:01

First-line treatment strategies for the management of la/mUC: S2 Ep 4 - Round Table Discussion